Results 191 to 200 of about 11,900 (212)
Objectives Subcutaneous depot medroxyprogesterone acetate (DMPA-SC) is seen as a valuable innovation in family planning, but little is known about trends in DMPA-SC use or characteristics of users. Using data from Burkina Faso, the Democratic Republic of
Georges Guiella +2 more
exaly +2 more sources
Highlights • From 2014 to 2016, the MOHs of Burkina Faso, Niger, Senegal and Uganda launched pilot introductions of the novel injectable contraceptive DMPA-SC.• This manuscript describes a four-phase approach to monitoring DMPA-SC pilot introduction ...
Allen Namagembe
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Contraception, 2017
OBJECTIVES Self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-sc) is feasible, acceptable, and effective. Our objective was to compare one-year continuation of DMPA-sc between women randomized to self-administration versus clinic
J. Kohn +8 more
semanticscholar +1 more source
OBJECTIVES Self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-sc) is feasible, acceptable, and effective. Our objective was to compare one-year continuation of DMPA-sc between women randomized to self-administration versus clinic
J. Kohn +8 more
semanticscholar +1 more source
Depot-Medroxyprogesterone Acetate (DMPA) and Cancer of the Endometrium and Ovary
Contraception, 1994Pisake Lumbiganon
exaly
Effects of DMPA on Weight and Blood Pressure in Long Term Acceptors
Contraception, 1999Unnop Jaisamrarn +2 more
exaly

